![Torbjørn Bjerke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Torbjørn Bjerke
Président chez
TXP Pharma AG (Switzerland)
Profil
Torbjørn Bjerke is the founder of TXP Pharma GmbH (founded in 2014), Action Pharma A (founded in 2000), and Arctic Asset Management AS (Sweden) (founded in 2016).
He held the title of Director at TXP Pharma GmbH and Action Pharma A. He is currently the Chairman at TXP Pharma AG (Switzerland), Director at Biothea Pharma, Inc., and Portfolio Manager at Arctic Funds Plc - Aurora LifeScience.
Dr. Bjerke's former positions include Chief Executive Officer at Karolinska Development AB (2011-2014), President & Chief Executive Officer at Biolipox AB (2004-2007), Chief Executive Officer at SynAct Pharma AB (2023-2024), Chief Executive Officer at Karolinska Development AB. (Private Equity) (2010-2014), Chairman, President & Chief Executive Officer at Orexo AB (2007-2011), and Independent Director at DBV Technologies SA (2012-2021).
He also has experience as a Director at various companies including AstraZeneca AB, Aprea Therapeutics AB, Topotarget A, Palette Life Sciences AB, and Action Pharma Holding.
I.
A. Dr. Bjerke obtained a doctorate degree from the University of Aarhus in 1989.
Postes actifs de Torbjørn Bjerke
| Sociétés | Poste | Début |
|---|---|---|
Arctic Funds Plc - Aurora LifeScience
 Arctic Funds Plc - Aurora LifeScience Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Corporate Officer/Principal | 01/01/2016 |
Biothea Pharma, Inc.
 Biothea Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals for allergic reactions & anaphylaxis | Directeur/Membre du Conseil | - |
TXP Pharma AG (Switzerland)
 TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases | Président | - |
Anciens postes connus de Torbjørn Bjerke
| Sociétés | Poste | Fin |
|---|---|---|
| SYNACT PHARMA AB | Directeur Général | 20/03/2024 |
Arctic Asset Management AS (Sweden)
 Arctic Asset Management AS (Sweden) Investment ManagersFinance AAM-Sweden employs an active approach that focuses on bringing long-term value creation to their clients. The firm’s Arctic Aurora LifeScience is a specialized global healthcare equity UCITS fund that invests primarily in European and US public life science companies. The investment strategy focuses on achieving excess return from investments in the biotechnology and pharmaceutical sector by investing in the most innovative companies developing new treatments that significantly change the life of patients to the benefit of society. | Fondateur | 01/05/2023 |
| DBV TECHNOLOGIES | Directeur/Membre du Conseil | 19/05/2021 |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Directeur Général | 31/10/2014 |
| KDVENTURES AB | Directeur Général | 30/09/2014 |
Formation de Torbjørn Bjerke
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
27
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 27 |
|---|---|
Arctic Funds Plc - Aurora LifeScience
Arctic Funds Plc - Aurora LifeScience Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Miscellaneous |
NTG Nordic Transport Group A/S
 NTG Nordic Transport Group A/S TruckingTransportation Transports goods through truck, ship and aircraft | Transportation |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Topotarget A/S
 Topotarget A/S Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceuticals | Health Technology |
ALK-Abello A/S
 ALK-Abello A/S Pharmaceuticals: MajorHealth Technology Develops and produces, markets products for diagnosing, treating allergies, allergic asthma & acute anaphylactic reactions | Health Technology |
Orexo AB
 Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Finance |
University of Aarhus
 University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products | Health Technology |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
Action Pharma A/S
 Action Pharma A/S BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds | Health Technology |
Axelar AB
 Axelar AB BiotechnologyHealth Technology Provides oral anti-cancer therapies | Health Technology |
Pergamum AB
 Pergamum AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products based on therapeutic peptides | Health Technology |
NeoDynamics AB
 NeoDynamics AB Medical SpecialtiesHealth Technology Develops equipment for diagnosis of breast cancer | Health Technology |
Action Pharma Holding I A/S | |
TBIOTECH ApS | |
Selskabet af 20.02.2002 ApS | |
Karolinska Development AB
 Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Develops products that improve the quality of life for patients | Health Technology |
Axela AB | |
KDev Investments AB
 KDev Investments AB BiotechnologyHealth Technology Engages in research, sales, and development in the fields of medicine and owns and manages investments | Health Technology |
SynAct Pharma AB
 SynAct Pharma AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs for treatment inflammatory diseases | Health Technology |
TXP Pharma GmbH | |
Arctic Asset Management AS (Sweden)
Arctic Asset Management AS (Sweden) Investment ManagersFinance AAM-Sweden employs an active approach that focuses on bringing long-term value creation to their clients. The firm’s Arctic Aurora LifeScience is a specialized global healthcare equity UCITS fund that invests primarily in European and US public life science companies. The investment strategy focuses on achieving excess return from investments in the biotechnology and pharmaceutical sector by investing in the most innovative companies developing new treatments that significantly change the life of patients to the benefit of society. | Finance |
Biothea Pharma, Inc.
Biothea Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals for allergic reactions & anaphylaxis | Health Technology |
TXP Pharma AG (Switzerland)
TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases | Health Technology |
